LaNCE-Neuropharm - GIC 21/133
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Marqués de Valdecilla (8)
2023
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
2016
2015
-
Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations
Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722
2013
-
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): A randomised trial
The Lancet, Vol. 382, Núm. 9890, pp. 397-408
2012
-
levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades
Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688
2009
-
Lrrk2 R1441G-related Parkinson's disease: Evidence of a common founding event in the seventh century in Northern Spain
Neurogenetics, Vol. 10, Núm. 4, pp. 347-353
2008
-
Tumores neuronales: Gangliocitoma
Revista de Neurologia, Vol. 46, Núm. 3, pp. 155-159
2006
-
El meduloblastoma
Revista de Neurologia, Vol. 43, Núm. 4, pp. 213-217